Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples
Clinical trial NCT03663400 · COMPLETED
Trial details
- NCT number
- NCT03663400
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-12-04
- Primary completion
- 2022-03-24
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.